|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
FridayWow! It's no wonder MS is seen as a Cash Cow: THESE MS DRUGS BROUGHT IN THE MOST MONEY LAST YEAR![]() #2 Avonex Biogen Idec $3.0 billion #3 Gilenya Novartis $1.9 billion #4 Tysabri Biogen Idec $1.7 billion #5 Betaseron Bayer $1.1 billion #6 Tecfidera Biogen Idec $0.9 billion #7 Rebif EMD serono $0.6 billion #8 Ampyra Biogen Idec $0.3 billion #9 Aubagio Sanofi $0.2 billion #10 Extavia Novartis $0.2 billion Read more » Labels: 20 Best Stories & Studies, Ampyra, Aubagio, Avonex, Betaseron, Extavia, Gilenya, Rebif, TECFIDERA, Tysabri SundayTHE AMAZING DOCTOR WHO WAS PART OF A TEAM WHO HELPED INVENT COPAXONE & REBIF & IS NOW FOCUSING ON STEM CELLS AT 75 |